Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy.
Transplant glomerulopathy (TGP) appears to be a pathogenic feature of chronic antibody-mediated rejection, but the pathogenesis of this histologic entity is still poorly understood. Previous studies suggest the involvement of lymphocytes but the phenotypes of these cells have never been analyzed. Here, we report the first study of mRNAs for specific markers of CD4+ T cells including Th1 (T-bet and INFgamma), Th2 (IL4 and GATA3), Treg (Foxp3) and Th17 (IL-17 and RORgammat) subsets, cytotoxic CD8 T cells (Granzyme B) and B-cell markers (CD20) in renal biopsies from renal transplant recipients suffering interstitial fibrosis and tubular atrophy (IF/TA) with or without TGP but with a similar inflammatory score and controls including transplant recipients with normal renal function. Only INFgamma, T-bet (both functionally defined markers of Th1 CD4 T cells) and granzyme B (a CD8 cytotoxic marker) were significantly more strongly expressed in patients with TGP than in patients without TGP and normal controls. These results indicate a role of an active T-mediated inflammatory and cytotoxic process in the pathogenesis of TGP.
Nephrology and Transplantation Unit, Henri Mondor Hospital and Centre de Recherche, INSERM 841, AP-HP, Institut Francilien de Recherche en Néphrologie et Transplantation, Paris XII University, Créteil, France.
S
S
Homs
H
H
Mansour
D
D
Desvaux
C
C
Diet
M
M
Hazan
M
M
Buchler
Y
Y
Lebranchu
D
D
Buob
C
C
Badoual
M
M
Matignon
V
V
Audard
P
P
Lang
P
P
Grimbert
D002196:Capillaries / Q000473:pathology; D018076:DNA, Complementary / Q000235:genetics; D024601:Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D010641:Phenotype; D011183:Postoperative Complications / Q000276:immunology* / Q000473:pathology; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012333:RNA, Messenger / Q000235:genetics; D012079:Renal Circulation; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*
D018076:DNA, Complementary; D012333:RNA, Messenger; D012313:RNA; D024601:Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)